Geert Cauwenbergh, President & CEO at RXi Pharmaceuticals Corp (RXII), bought 2,000 shares at $2.91 ($6K) on 2014-06-04, disclosed to the SEC on 2014-06-05.
Open-market purchase of $6k RXII by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.91 | 1,000 | $3K | 49.5% |
| 2 | $2.97 | 1,000 | $3K | 50.5% |
| Total | $2.94 avg | 2,000 | $6K | 100% |
| Filing → |
| RXII | BUY | 2017-06-22 | $6K | — | Filing → |
| RXII | BUY | 2017-04-26 | $7K | — | Filing → |
| RXII | BUY | 2017-03-20 | $8K | — | Filing → |